Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic
Batool A Haider(Aga Khan University), Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), James McGrory(Alkermes (United States)), Leona Bessonova(Alkermes (United States)), Jeffrey P Trotter(Triangle), Philip D. Harvey(University of Miami), Eric D. Achtyes(Pine Rest Christian Mental Health Services), Asia Sikora Kessler(Optum (United States)), Wahidullah Noori(Alkermes (United States)), Tiffany Polak(Alkermes (United States)), Amy Claxton(Bristol-Myers Squibb (Germany)), Stephen R. Saklad, Elizabeth Keane(Alkermes (United States)), John M. Kane(University of North Carolina at Chapel Hill), Amy K. O’Sullivan(Alkermes (United States)), Aaron Yarlas
Cited by 3
Related Papers
What works? Interventions for maternal and child undernutrition and survival
|The Lancet|2008|2.3k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Schizophrenia
|Nature Reviews Disease Primers|2015|1.1k
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program
|American Journal of Psychiatry|2015|849